Cargando…

Predicting response to recombinant activated factor VIIa administration in the critically ill

Detalles Bibliográficos
Autores principales: Pugh, R, Wenstone, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088594/
http://dx.doi.org/10.1186/cc6444
_version_ 1782324982838198272
author Pugh, R
Wenstone, R
author_facet Pugh, R
Wenstone, R
author_sort Pugh, R
collection PubMed
description
format Online
Article
Text
id pubmed-4088594
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40885942014-07-11 Predicting response to recombinant activated factor VIIa administration in the critically ill Pugh, R Wenstone, R Crit Care Poster Presentation BioMed Central 2008 2008-03-13 /pmc/articles/PMC4088594/ http://dx.doi.org/10.1186/cc6444 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Poster Presentation
Pugh, R
Wenstone, R
Predicting response to recombinant activated factor VIIa administration in the critically ill
title Predicting response to recombinant activated factor VIIa administration in the critically ill
title_full Predicting response to recombinant activated factor VIIa administration in the critically ill
title_fullStr Predicting response to recombinant activated factor VIIa administration in the critically ill
title_full_unstemmed Predicting response to recombinant activated factor VIIa administration in the critically ill
title_short Predicting response to recombinant activated factor VIIa administration in the critically ill
title_sort predicting response to recombinant activated factor viia administration in the critically ill
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088594/
http://dx.doi.org/10.1186/cc6444
work_keys_str_mv AT pughr predictingresponsetorecombinantactivatedfactorviiaadministrationinthecriticallyill
AT wenstoner predictingresponsetorecombinantactivatedfactorviiaadministrationinthecriticallyill